NCT04715048View on ClinicalTrials.gov

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Glabellar Frown Lines
Interventions
DRUG

PrabotulinumtoxinA

Glabellar line correction

DRUG

Onabotulinum toxin A

Glabellar line correction

Trial Locations (1)

90033

USC Roski Eye Institute, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER